The S2 subunit of infectious bronchitis virus beaudette is a determinant of cellular tropism

Journal of Virology

Volumn 92, Issue 19, 2018, Pages

  Bickerton, Erica ^a   Maier, Helena J ^a   Stevenson Leggett, Phoebe ^a   Armesto, Maria ^a   Britton, Paul ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Coronavirus; Infectious bronchitis virus; Reverse genetic analysis; S2= Cellular tropism

Indexed keywords

CORONAVIRUS SPIKE GLYCOPROTEIN;

ANIMAL; AVIAN INFECTIOUS BRONCHITIS VIRUS; CHICKEN; CHLOROCEBUS AETHIOPS; CORONAVIRUS INFECTION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN SUBUNIT; VERO CELL LINE; VIRAL TROPISM; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; CHICKENS; CORONAVIRUS INFECTIONS; INFECTIOUS BRONCHITIS VIRUS; PROTEIN SUBUNITS; SPIKE GLYCOPROTEIN, CORONAVIRUS; VERO CELLS; VIRAL TROPISM; VIRUS REPLICATION;

EID: 85053405096     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01044-18     Document Type: Article

References (98)

1. Carstens EB. 2010. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch Virol 155:133–146. https://doi.org/10.1007/s00705-009-0547-x.
2. Cavanagh D. 2005. Coronaviruses in poultry and other birds. Avian Pathol 34:439–448. https://doi.org/10.1080/03079450500367682.
3. Cavanagh D, Gelb J, Jr. 2008. Infectious bronchitis, p 117–135. In Saif YM (ed), Diseases of poultry, 12th ed. Blackwell Publishing, Ames, IA.
4. Jones RC. 2010. Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control? Br Poult Sci 51:1–11. https://doi.org/10.1080/00071660903541378.
5. de Wit JJ, Cook JKA, van der Heijden HMJF. 2011. Infectious bronchitis virus variants: a review of the history, current situation and control measures. Avian Pathol 40:223–235. https://doi.org/10.1080/03079457.2011.566260.
6. Cavanagh D, Naqi S. 2003. Infectious bronchitis, p 101–119. In Saif YM, Barnes HJ, Glisson JR, Fadly AM, McDougald LR, Swayne DE (ed), Diseases of poultry, 11th ed. Iowa State University Press, Ames, IA.
7. Britton P, Cavanagh D. 2007. Avian coronavirus diseases and infectious bronchitis vaccine development, p 161–181. In Thiel V (ed), Coronaviruses: molecular and cellular biology. Caister Academic Press, Norfolk, United Kingdom.
8. Hodgson T, Casais R, Dove B, Britton P, Cavanagh D. 2004. Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity. J Virol 78:13804–13811. https://doi.org/10.1128/JVI.78.24.13804-13811.2004.
9. Ambali AG, Jones RC. 1990. Early pathogenesis in chicks of infection with an enterotropic strain of infectious bronchitis virus. Avian Dis 34: 809 – 817. https://doi.org/10.2307/1591367.
10. Cavanagh D. 2007. Coronavirus avian infectious bronchitis virus. Vet Res 38:281–297. https://doi.org/10.1051/vetres:2006055.
11. Lambrechts C, Pensaert M, Ducatelle R. 1993. Challenge experiments to evaluate cross-protection induced at the trachea and kidney level by vaccine strains and Belgian nephropathogenic isolates of avian infectious bronchitis virus. Avian Pathol 22:577–590. https://doi.org/10.1080/03079459308418945.
12. Ziegler AF, Ladman BS, Dunn PA, Schneider A, Davison S, Miller PG, Lu H, Weinstock D, Salem M, Eckroade RJ, Gelb J. 2002. Nephropathogenic infectious bronchitis in Pennsylvania chickens 1997–2000. Avian Dis 46:847–858. https://doi.org/10.1637/0005-2086(2002)046[0847:NIBIPC]2.0.CO;2.
13. Britton P, Cavanagh D. 2008. Nidovirus genome organization and expression mechanisms, p 29 – 46. In Perlman S, Gallagher T, Snijder EJ (ed), Nidoviruses. ASM Press, Washington, DC.
14. de Vries AAF, Horzinek MC, Rottier PJM, de Groot RJ. 1997. The genome organisation of the Nidovirales: similarities and differences between arteri-, toro- and coronaviruses. Semin Virol 8:33–47. https://doi.org/10.1006/smvy.1997.0104.
15. Lai MM, Cavanagh D. 1997. The molecular biology of coronaviruses. Adv Virus Res 48:1–100.
16. Delmas B, Laude H. 1990. Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol 64:5367–5375.
17. Vennema H, Rottier PJ, Heijnen L, Godeke GJ, Horzinek MC, Spaan WJ. 1990. Biosynthesis and function of the coronavirus spike protein. Adv Exp Med Biol 276:9–19. https://doi.org/10.1007/978-1-4684-5823-7_3.
18. Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77:8801–8811. https://doi.org/10.1128/JVI.77.16.8801-8811.2003.
19. Walls AC, Tortorici MA, Bosch BJ, Frenz B, Rottier PJ, DiMaio F, Rey FA, Veesler D. 2016. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 531:114–117. https://doi.org/10.1038/nature16988.
20. Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, Corbett KS, Graham BS, McLellan JS, Ward AB. 2016. Pre-fusion structure of a human coronavirus spike protein. Nature 531:118–121. https://doi.org/10.1038/nature17200.
21. Shang J, Zheng Y, Yang Y, Liu C, Geng Q, Luo C, Zhang W, Li F. 2018. Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins. PLoS Pathog 14:e1007009. https://doi.org/10.1371/journal.ppat.1007009.
22. Gallagher TM, Buchmeier MJ. 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279:371–374. https://doi.org/10.1006/viro.2000.0757.
23. De Haan CA, Stadler K, Godeke GJ, Bosch BJ, Rottier PJ. 2004. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol 78:6048 – 6054. https://doi.org/10.1128/JVI.78.11.6048-6054.2004.
24. Sturman LS, Ricard CS, Holmes KV. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J Virol 56:904–911.
25. Spaan W, Cavanagh D, Horzinek MC. 1988. Coronaviruses: structure and genome expression. J Gen Virol 69:2939–2952. https://doi.org/10.1099/0022-1317-69-12-2939.
26. Koch G, Hartog L, Kant A, van Roozelaar DJ. 1990. Antigenic domains of the peplomer protein of avian infectious bronchitis virus: correlation with biological function. J Gen Virol 71:1929–1935. https://doi.org/10.1099/0022-1317-71-9-1929.
27. Schultze B, Cavanagh D, Herrler G. 1992. Neuraminidase treatment of avian infectious bronchitis coronavirus reveals a hemagglutinating activity that is dependent on sialic acid-containing receptors on erythrocytes. Virology 189:792–794. https://doi.org/10.1016/0042-6822(92)90608-R.
28. Zelus BD, Schickli JH, Blau DM, Weiss SR, Holmes KV. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol 77:830–840. https://doi.org/10.1128/JVI.77.2.830-840.2003.
29. Matsuyama S, Taguchi F. 2009. Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and pro-teolysis. J Virol 83:11133–11141. https://doi.org/10.1128/JVI.00959-09.
30. Walls AC, Tortorici MA, Snijder J, Xiong X, Bosch BJ, Rey FA, Veesler D. 2017. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci U S A 114: 11157–11162. https://doi.org/10.1073/pnas.1708727114.
31. Risco C, Anton IM, Enjuanes L, Carrascosa JL. 1996. The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins. J Virol 70:4773–4777.
32. Luo ZL, Weiss SR. 1998. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology 244:483–494. https://doi.org/10.1006/viro.1998.9121.
33. Xu Y, Lou Z, Liu Y, Pang H, Tien P, Gao GF, Rao Z. 2004. Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core. J Biol Chem 279:49414–49419. https://doi.org/10.1074/jbc.M408782200.
34. Lu L, Liu Q, Zhu Y, Chan K, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen K, Zhang R, Jiang S. 2014. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Com-mun 5:3067. https://doi.org/10.1038/ncomms4067.
35. Zheng Q, Deng Y, Liu J, Van der Hoek L, Berkhout B, Lu M. 2006. Core structure of S2 from the human coronavirus NL63 spike glycoprotein. Biochemistry 45:15205–15215. https://doi.org/10.1021/bi061686w.
36. Xu Y, Liu Y, Lou Z, Qin L, Li X, Bai Z, Pang H, Tien P, Gao GF, Rao Z. 2004. Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem 279:30514–30522.
37. Duquerroy S, Vigouroux A, Rottier PJ, Rey FA, Jan Bosch B. 2005. Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology 335:276–285. https://doi.org/10.1016/j.virol.2005.02.022.
38. Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y, Geng H, Li H, Wang Q, Xiao H, Tan W, Yan J, Gao GF. 2013. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 87:13134–13140. https://doi.org/10.1128/JVI.02433-13.
39. Supekar VM, Bruckmann C, Ingallinella P, Bianchi E, Pessi A, Carfi A. 2004. Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proc Natl Acad Sci U S A 101:17958 –17963. https://doi.org/10.1073/pnas.0406128102.
40. de Groot RJ, Lujtjes W, Horzinek MC, van der Zeijst BAM, Spaan WJ, Lenstra JA. 1987. Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol 196:963–966. https://doi.org/10.1016/0022-2836(87)90422-0.
41. Tripet B, Howard MW, Jobling M, Holmes RK, Holmes KV, Hodges RS. 2004. Structural characterization of the SARS-coronavirus spike S fusion protein core. J Biol Chem 279:20836–20849. https://doi.org/10.1074/jbc.M400759200.
42. Guo Y, Tisoncik J, McReynolds S, Farzan M, Prabhakar BS, Gallagher T, Rong L, Caffrey M. 2009. Identification of a new region of SARS-CoV S protein critical for viral entry. J Mol Biol 394:600–605. https://doi.org/10.1016/j.jmb.2009.10.032.
43. Shulla A, Gallagher T. 2009. Role of spike protein endodomains in regulating coronavirus entry. J Biol Chem 284:32725–32734. https://doi.org/10.1074/jbc.M109.043547.
44. Opstelten DJ, Raamsman MJ, Wolfs K, Horzinek MC, Rottier PJ. 1995. Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol 131:339–349. https://doi.org/10.1083/jcb.131.2.339.
45. de Haan CA, Smeets M, Vernooij F, Vennema H, Rottier PJ. 1999. Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol 73:7441–7452.
46. Kubo H, Yamada YK, Taguchi F. 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J Virol 68: 5403–5410.
47. Bonavia A, Zelus BD, Wentworth DE, Talbot PJ, Holmes KV. 2003. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J Virol 77:2530–2538. https://doi.org/10.1128/JVI.77.4.2530-2538.2003.
48. Babcock GJ, Esshaki DJ, Thomas WD, Jr, Ambrosino DM. 2004. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78: 4552–4560. https://doi.org/10.1128/JVI.78.9.4552-4560.2004.
49. Promkuntod N, van Eijndhoven RE, de Vrieze G, Grone A, Verheije MH. 2014. Mapping of the receptor-binding domain and amino acids critical for attachment in the spike protein of avian coronavirus infectious bronchitis virus. Virology 448:26–32. https://doi.org/10.1016/j.virol.2013.09.018.
50. Delmas B, Gelfi J, L’Haridon R, Vogel LK, Sjöström H, Norén O, Laude H. 1992. Aminopeptidase N is a major receptor for the enteropatho-genic coronavirus TGEV. Nature 357:417–420. https://doi.org/10.1038/357417a0.
51. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, Holmes KV. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420–422. https://doi.org/10.1038/357420a0.
52. Tresnan DB, Levis R, Holmes KV. 1996. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 70:8669 – 8674.
53. Williams RK, Jiang G-S, Holmes KV. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A 88:5533–5536.
54. Langereis MA, van Vliet AL, Boot W, de Groot RJ. 2010. Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein. J Virol 84: 8970–8974. https://doi.org/10.1128/JVI.00566-10.
55. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450 – 454. https://doi.org/10.1038/nature02145.
56. Jeffers SA, Tusell SM, Gillim-Ross L, Hemmila EM, Achenbach JE, Babcock GJ, Thomas WD, Jr, Thackray LB, Young MD, Mason RJ, Ambrosino DM, Wentworth DE, Demartini JC, Holmes KV. 2004. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 101:15748–15753. https://doi.org/10.1073/pnas.0403812101.
57. Han DP, Lohani M, Cho MW. 2007. Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol 81:12029–12039. https://doi.org/10.1128/JVI.00315-07.
58. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Oster-haus AD, Bosch BJ, Haagmans BL. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251–254. https://doi.org/10.1038/nature12005.
59. Winter C, Schwegmann-Wessels C, Cavanagh D, Neumann U, Herrler G. 2006. Sialic acid is a receptor determinant for infection of cells by avian infectious bronchitis virus. J Gen Virol 87:1209–1216. https://doi.org/10.1099/vir.0.81651-0.
60. Wickramasinghe IN, de Vries RP, Grone A, de Haan CA, Verheije MH. 2011. Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity. J Virol 85:8903–8912. https://doi.org/10.1128/JVI.05112-11.
61. Winter C, Herrler G, Neumann U. 2008. Infection of the tracheal epithelium by infectious bronchitis virus is sialic acid dependent. Microbes Infect 10:367–373. https://doi.org/10.1016/j.micinf.2007.12.009.
62. Abd El Rahman S, El-Kenawy AA, Neumann U, Herrler G, Winter C. 2009. Comparative analysis of the sialic acid binding activity and the tropism for the respiratory epithelium of four different strains of avian infectious bronchitis virus. Avian Pathol 38:41– 45. https://doi.org/10.1080/03079450802632049.
63. Madu IG, Chu VC, Lee H, Regan AD, Bauman BE, Whittaker GR. 2007. Heparan sulfate is a selective attachment factor for the avian coronavirus infectious bronchitis virus Beaudette. Avian Dis 51:45–51. https://doi.org/10.1637/0005-2086(2007)051[0045:HSIASA]2.0.CO;2.
64. Yamada Y, Liu DX. 2009. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. J Virol 83:8744 – 8758. https://doi.org/10.1128/JVI.00613-09.
65. Tay F, Huang M, Wang L, Yamada Y, Liu DX. 2012. Characterization of cellular furin content as a potential factor determining the susceptibility of cultured human and animal cells to coronavirus infectious bronchitis virus infection. Virology 433:421–430. https://doi.org/10.1016/j.virol.2012.08.037.
66. Belouzard S, Chu VC, Whittaker GR. 2009. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 106:5871–5876. https://doi.org/10.1073/pnas.0809524106.
67. Millet JK, Whittaker GR. 2014. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A 111:15214–15219. https://doi.org/10.1073/pnas.1407087111.
68. Millet JK, Goldstein M, Labitt RN, Hsu H, Daniel S, Whittaker GR. 2016. A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties. Emerg Microbes Infect 5:e126. https://doi.org/10.1038/emi.2016.125.
69. Bonnin A, Danneels A, Dubuisson J, Goffard A, Belouzard S. 2018. HCoV-229E spike protein fusion activation by trypsin-like serine pro-teases is mediated by proteolytic processing in the S2= region. J Gen Virol 99:908–912. https://doi.org/10.1099/jgv.0.001074.
70. Sanchez CM, Izeta A, Sanchez-Morgado JM, Alonso S, Sola I, Balasch M, Plana-Duran J, Enjuanes L. 1999. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence. J Virol 73:7607–7618.
71. Tekes G, Hofmann-Lehmann R, Bank-Wolf B, Maier R, Thiel HJ, Thiel V. 2010. Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J Virol 84:1326–1333. https://doi.org/10.1128/JVI.01568-09.
72. Cunningham CH, Spring MP, Nazerian K. 1972. Replication of avian infectious bronchitis virus in African green monkey kidney cell line VERO. J Gen Virol 16:423– 427. https://doi.org/10.1099/0022-1317-16-3-423.
73. Otsuki K, Noro K, Yamamoto H, Tsubokura M. 1979. Studies on avian infectious bronchitis virus (IBV). II. Propagation of IBV in several cultured cells. Arch Virol 60:115–122.
74. Casais R, Dove B, Cavanagh D, Britton P. 2003. Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism. J Virol 77:9084–9089. https://doi.org/10.1128/JVI.77.16.9084-9089.2003.
75. Casais R, Thiel V, Siddell SG, Cavanagh D, Britton P. 2001. Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol 75:12359–12369. https://doi.org/10.1128/JVI.75.24.12359-12369.2001.
76. Britton P, Evans S, Dove B, Davies M, Casais R, Cavanagh D. 2005. Generation of a recombinant avian coronavirus infectious bronchitis virus using transient dominant selection. J Virol Methods 123:203–211. https://doi.org/10.1016/j.jviromet.2004.09.017.
77. Armesto M, Casais R, Cavanagh D, Britton P. 2008. Transient dominant selection for the modification and generation of recombinant infectious bronchitis coronaviruses. Methods Mol Biol 454:255–273. https://doi.org/10.1007/978-1-59745-181-9_19.
78. Armesto M, Evans S, Cavanagh D, Abu-Median AB, Keep S, Britton P. 2011. A recombinant avian infectious bronchitis virus expressing a heterologous spike gene belonging to the 4/91 serotype. PLoS One 6:e24352. https://doi.org/10.1371/journal.pone.0024352.
79. Frazatti-Gallina NM, Mourao-Fuches RM, Paoli RL, Silva MLN, Miyaki C, Valentini EJG, Raw I, Higashi HG. 2004. Vero-cell rabies vaccine produced using serum-free medium. Vaccine 23:511–517. https://doi.org/10.1016/j.vaccine.2004.06.014.
80. Montagnon BJ, Fanget B, Nicolas AJ. 1981. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev Biol Stand 47: 55–64.
81. Govorkova EA, Murti G, Meignier B, De Taisne C, Webster RG. 1996. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J Virol 70:5519–5524.
82. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Dorner F. 1998. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16:960–968. https://doi.org/10.1016/S0264-410X(97)00301-0.
83. Geilhausen HE, Ligon FB, Lukert PD. 1973. The pathogenesis of virulent and avirulent avian infectious bronchitis virus. Arch Gesamte Virusforsch 40:285–290.
84. Van Roekel H, Clarke MK, Bullis KL, Olesiuk OM, Sperling FG. 1951. Infectious bronchitis. Am J Vet Res 12:140–146.
85. Cook JKA, Darbyshire JH, Peters RW. 1976. The use of chicken tracheal organ cultures for the isolation and assay of avian infectious bronchitis virus. Arch Virol 50:109–118. https://doi.org/10.1007/BF01318005.
86. Darbyshire JH, Rowell JG, Cook JKA, Peters RW. 1979. Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Arch Virol 61:227–238. https://doi.org/10.1007/BF01318057.
87. Beaudette FR, Hudson CB. 1937. Cultivation of the virus of infectious bronchitis. J Am Vet Med Assoc 90:51–60.
88. Cavanagh D, Davis PJ, Pappin DJC, Binns MM, Boursnell MEG, Brown TDK. 1986. Coronavirus IBV: partial amino terminal sequencing of spike polypeptide S2 identifies the sequence Arg-Arg-Phe-Arg-Arg at the cleavage site of the spike precursor propolypeptide of IBV strains Beaudette and M41. Virus Res 4:133–143. https://doi.org/10.1016/0168-1702(86)90037-7.
89. Pénzes Z, Tibbles K, Shaw K, Britton P, Brown TDK, Cavanagh D. 1994. Characterization of a replicating and packaged defective RNA of avian coronavirus infectious bronchitis virus. Virology 203:286 –293. https://doi.org/10.1006/viro.1994.1486.
90. Pénzes Z, Wroe C, Brown TD, Britton P, Cavanagh D. 1996. Replication and packaging of coronavirus infectious bronchitis virus defective RNAs lacking a long open reading frame. J Virol 70:8660–8668.
91. Stirrups K, Shaw K, Evans S, Dalton K, Cavanagh D, Britton P. 2000. Leader switching occurs during the rescue of defective RNAs by heterologous strains of the coronavirus infectious bronchitis virus. J Gen Virol 81:791–801. https://doi.org/10.1099/0022-1317-81-3-791.
92. Wickramasinghe IN, van Beurden SJ, Weerts EA, Verheije MH. 2014. The avian coronavirus spike protein. Virus Res 194:37–48. https://doi.org/10.1016/j.virusres.2014.10.009.
93. Cunningham CH. 1970. Avian infectious bronchitis. Adv Vet Sci 14: 106–148.
94. Cunningham CH. 1975. Immunity to avian infectious bronchitis, p 546–562. In Perkins FT, Regamey RH (ed), Immunity to infections of the respiratory system in man and animals, vol 28. Karger, London, United Kingdom.
95. Bickerton E. 2011. PhD thesis. University of Warwick, United Kingdom.
96. Armesto M, Bentley K, Bickerton E, Keep S, Britton P. 2012. Coronavirus reverse genetics, p 27–63. In Bridgen A (ed), Reverse genetics of RNA viruses: applications and perspectives. Wiley-Blackwell Press, Oxford, United Kingdom.
97. Boursnell MEG, Brown TDK, Foulds IJ, Green PF, Tomley FM, Binns MM. 1987. Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus. J Gen Virol 68:57–77. https://doi.org/10.1099/0022-1317-68-1-57.
98. Bonfield JK, Smith KF, Staden R. 1995. A new DNA sequence assembly program. Nucleic Acids Res 23:4992–4999. https://doi.org/10.1093/nar/23.24.4992.